株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国のアンブロキソール市場の分析

Investigation Report on China's Ambroxol Market, 2018-2022

発行 China Research and Intelligence 商品コード 334087
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.21円で換算しております。
Back to Top
中国のアンブロキソール市場の分析 Investigation Report on China's Ambroxol Market, 2018-2022
出版日: 2018年11月14日 ページ情報: 英文 30 Pages
概要

アンブロキソールは、中国市場に参入以降、急成長しています。年間売上高は、2005年の2億人民元から、2014年には9億4,300万人民元に達し、CAGRで20.9%の成長を遂げました。

当レポートでは、中国のアンブロキソール市場について調査分析し、市場規模、競合情勢、企業別の小売価格、市場見通しについて、体系的な情報を提供しています。

第1章 アンブロキソールの関連概念

  • 適応
  • 世界市場の販売状況

第2章 中国のアンブロキソールの市場プロファイル

  • 中国のアンブロキソールの特許・承認状況
  • 主要メーカー
  • 市場規模

第3章 中国のアンブロキソールの販売分析

  • 売上高
  • 売上数量

第4章 中国のアンブロキソール主要メーカーの市場シェア分析

  • 市場シェア:売上高別
  • 市場シェア:売上数量別

第5章 中国のアンブロキソールの剤形別の分析

  • 市場シェア (剤形別) :売上高別
  • 市場シェア (剤形別) :売上数量別

第6章 中国のアンブロキソールの病院向け基準価格

第7章 中国市場のアンブロキソールの主要メーカー

  • TIPR Pharmaceutical Responsible Co., Ltd
  • Shenya Xin Ma Pharmaceutical Co., Ltd
  • Changzhou Siyao Pharmaceuticals Co., Ltd
  • Boehringer Ingelheim
  • Boehringer Ingelheim (Shanghai)

第8章 中国のアンブロキソールの市場見通し

  • 市場規模の予測
  • 競合情勢の予測

図表

目次
Product Code: 1811347

Description

According to CRI, the incidence and case fatality rate of respiratory diseases in China are high in recent years. Following cardiovascular and cerebrovascular diseases and cancers, respiratory diseases rank third among the chronic diseases that cause deaths in China. Therefore, developing drugs for the treatment of respiratory diseases has become an important part of drug research. In the case of respiratory infections (respiratory diseases such as chronic bronchitis), a large amount of sputum is produced, which requires the application of expectorants. Respiratory mucus regulators are the main expectorants.

After years of development, third-generation expectorant Ambroxol has become the most common drug in the clinical treatment of respiratory diseases. The chemical constituent of Ambroxol is ambroxol hydrochloride, an active metabolite of Bromhexine. In 1981, Ambroxol (trade name: Mucosolvan) developed by German company Boehringer Ingelheim was launched. Compared with the first and second generations of expectorants, Ambroxol excels in dissolving mucus. In 1994, Boehringer Ingelheim's Ambroxol entered China. Afterwards, the generic drugs by Chinese companies also came onto the market.

According to CRI's market research, Ambroxol has been growing rapidly since it entered China. From 2005 to 2014, its annual sales value increased from less than CNY 200 million to CNY 1.26 billion, representing a CAGR of 20.9%. From 2015 to 2017, the sales revenue of Ambroxol declined in China. By sales value, Boehringer Ingelheim takes up a market share of about 44%. The rest market share is captured by Chinese companies, among which the top market players are Changzhou Siyao Pharmaceuticals Co., Ltd., Shenyang Xinma Pharmaceutical Co., Ltd., TIPR Pharmaceutical Responsible Co., Ltd. and Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of injections, solutions, syrups, granules, tablets and capsules. Injections dominate the market.

As environmental pollution and population aging intensify, the incidence of respiratory diseases will keep rising, it is expected that Ambroxol will still have some growth potential in China in the next few years.

Topics Covered:

  • Situation of respiratory diseases in China
  • Size of China's Ambroxol market
  • Competitive landscape of China's Ambroxol market
  • Prices of Ambroxol in China
  • Analysis on factors affecting the development of China's Ambroxol market
  • Prospect of China's Ambroxol market from 2018 to 2022

Table of Contents

Table of Contents

1 Relevant Concepts of Ambroxol

  • 1.1 Indications for Ambroxol
  • 1.2 Development of Ambroxol in China
  • 1.3 Governmental Approval of Ambroxol in China

2 Sales of Ambroxol in China, 2013-2017

  • 2.1 Sales Value of Ambroxol
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Ambroxol
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Ambroxol by Dosage Form in China, 2013-2017
    • 2.3.1 Tablets
    • 2.3.2 Capsules
    • 2.3.3 Injections
    • 2.3.4 Solutions
    • 2.3.5 Syrups
    • 2.3.6 Granules

3 Analysis on Major Ambroxol Manufacturers in China, 2013-2017

  • 3.1 Analysis on Market Share of Major Ambroxol Manufacturers
    • 3.1.1 Market Share by Sales Value
    • 3.1.2 Market Share by Sales Volume
  • 3.2 Boehringer Ingelheim
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Boehringer Ingelheim's Ambroxol in China
  • 3.3 Changzhou Siyao Pharmaceuticals Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Ambroxol in China
  • 3.4 Shenyang Xinma Pharmaceutical Co., Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Shenyang Xinma Pharmaceutical Co., Ltd.'s Ambroxol in China
  • 3.5 TIPR Pharmaceutical Responsible Co., Ltd.
    • 3.5.1 Enterprise Profile
    • 3.5.2 Sales of TIPR Pharmaceutical Responsible Co., Ltd.'s Ambroxol in China
  • 3.6 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.
    • 3.6.1 Enterprise Profile
    • 3.6.2 Sales of Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd.'s Ambroxol in China

4 Prices of Ambroxol in China, 2017-2018

  • 4.1 Boehringer Ingelheim (Mucosolvan)
  • 4.2 Changzhou Siyao Pharmaceuticals Co., Ltd. (Lansu)
  • 4.3 Shenyang Xinma Pharmaceutical Co., Ltd. (Kaishun)
  • 4.4 TIPR Pharmaceutical Responsible Co., Ltd. (Yinuoshu)
  • 4.5 Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)

5 Prospect of China's Ambroxol Market, 2018-2022

  • 5.1 Forecast on Market Size
  • 5.2 Forecast on Market Trend

Selected Charts

  • Chart Governmental Approval of Ambroxol in China
  • Chart Sales of Ambroxol in China, 2013-2017
  • Chart Sales Value of Ambroxol in Parts of China, 2013-2017
  • Chart Sales Volume of Ambroxol in China, 2013-2017
  • Chart Sales Volume of Ambroxol in Parts of China, 2013-2017
  • Chart Sales Value of Ambroxol Tablets in China, 2013-2017
  • Chart Sales Volume of Ambroxol Tablets in China, 2013-2017
  • Chart Sales Value of Ambroxol Capsules in China, 2013-2017
  • Chart Sales Volume of Ambroxol Capsules in China, 2013-2017
  • Chart Sales Value of Ambroxol Injections in China, 2013-2017
  • Chart Market Share by Sales Value of Top 5 Ambroxol Manufacturers in China, 2013-2017
  • Chart Sales Value of Boehringer Ingelheim's Ambroxol in China, 2013-2017
  • Chart Sales Volume of Boehringer Ingelheim's Ambroxol in China, 2013-2017
  • Chart Sales Value of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Ambroxol in China, 2013-2017
  • Chart Sales Value of Shenyang Xinma Pharmaceutical Co., Ltd.'s Ambroxol in China, 2013-2017
  • Chart Prices of Boehringer Ingelheim's Ambroxol in Parts of China, 2017-2018
  • Chart Prices of Changzhou Siyao Pharmaceuticals Co., Ltd.'s Ambroxol in Parts of China, 2017-2018
  • Chart Prices of Shenyang Xinma Pharmaceutical Co., Ltd.'s Ambroxol in Parts of China, 2017-2018
  • Chart Prices of TIPR Pharmaceutical Responsible Co., Ltd.'s Ambroxol in Parts of China, 2017-2018
  • Chart Forecast on Sales Value of Ambroxol in China, 2018-2022
Back to Top